X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (471) 471
Patent (51) 51
Book Chapter (8) 8
Dissertation (5) 5
Conference Proceeding (4) 4
Magazine Article (2) 2
Book / eBook (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
female (91) 91
animals (86) 86
oncology (83) 83
male (70) 70
chemistry (61) 61
middle aged (55) 55
adult (54) 54
materials science, multidisciplinary (54) 54
chemistry, multidisciplinary (53) 53
research (51) 51
adhesives (49) 49
aged (47) 47
mice (45) 45
metallurgy (43) 43
cancer (39) 39
chemistry, physical (39) 39
analysis (37) 37
compositions based thereon (36) 36
organic macromolecular compounds (36) 36
their preparation or chemical working-up (36) 36
dyes (35) 35
miscellaneous applications of materials (35) 35
miscellaneous compositions (35) 35
natural resins (35) 35
paints (35) 35
polishes (35) 35
materials science, biomaterials (32) 32
proteins (31) 31
polymers (30) 30
nanoscience & nanotechnology (28) 28
mytilus-edulis (27) 27
colorectal cancer (25) 25
surface properties (25) 25
tumors (25) 25
polymers - chemistry (24) 24
management (23) 23
medicine & public health (23) 23
performing operations (23) 23
transporting (23) 23
care and treatment (22) 22
human necessities (22) 22
pharmacology & pharmacy (22) 22
polymer science (22) 22
polyethylene glycols - chemistry (21) 21
treatment outcome (21) 21
aged, 80 and over (20) 20
growth (20) 20
nanoparticles (20) 20
dopa (19) 19
nanotechnology (19) 19
polydopamine (19) 19
surgery (19) 19
adhesive processes not provided for elsewhere (18) 18
chemotherapy (18) 18
engineering, biomedical (18) 18
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (18) 18
non-mechanical aspects of adhesive processes in general (18) 18
polymer (18) 18
protein (18) 18
use of materials as adhesives (18) 18
adsorption (17) 17
cell line, tumor (17) 17
compositions of macromolecular compounds (17) 17
hydrogels - chemistry (17) 17
hygiene (17) 17
medical or veterinary science (17) 17
neoplasms - drug therapy (17) 17
studies (17) 17
time factors (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
chemistry, organic (16) 16
colorectal neoplasms - drug therapy (16) 16
cross-linking (16) 16
expression (16) 16
hydrogels (16) 16
multidisciplinary sciences (16) 16
pharmacology/toxicology (16) 16
poly (16) 16
polymerization (16) 16
protein adsorption (16) 16
therapy (16) 16
xenograft model antitumor assays (16) 16
adhesion (15) 15
biochemistry & molecular biology (15) 15
biomimetics (15) 15
dihydroxyphenylalanine - chemistry (15) 15
metastasis (15) 15
pharmacokinetics (15) 15
usage (15) 15
young adult (15) 15
antineoplastic agents - therapeutic use (14) 14
biomimetic materials - chemistry (14) 14
health aspects (14) 14
manufacture or treatment of nanostructures (14) 14
materials science (14) 14
measurement or analysis of nanostructures (14) 14
mutation (14) 14
patients (14) 14
specific uses or applications of nanostructures (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2015, Volume 33, Issue 34, pp. 4023 - 4031
Journal Article
Journal Article
Composites science and technology, ISSN 0266-3538, 2008, Volume 68, Issue 9, pp. 2042 - 2048
Journal Article
Annual review of materials research, ISSN 1531-7331, 8/2011, Volume 41, Issue 1, pp. 99 - 132
Mussels attach to solid surfaces in the sea. Their adhesion must be rapid, strong, and tough, or else they will be dislodged and dashed to pieces by the next... 
Dopa | mussel foot proteins | adhesion energy | wet adhesion | byssus | Adhesion energy | Wet adhesion | Byssus | Mussel foot proteins | ATTACHMENT PLAQUE | LINKING ADHESIVE | PROTEIN | SANDCASTLE GLUE | MATERIALS SCIENCE, MULTIDISCIPLINARY | POLYPEPTIDE MIMICS | CROSS-LINKING | MYTILUS-EDULIS | PROTECTIVE-COATINGS | SURFACE-ENERGY | Physiological aspects | Catechin | Research | Properties | Mussels | Adhesion
Journal Article
Nature (London), ISSN 1476-4687, 2007, Volume 448, Issue 7151, pp. 338 - 341
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 07/2014, Volume 12, Issue 7, pp. 1028 - 1059
The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance,... 
PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | UNRESECTABLE LIVER METASTASES | BEVACIZUMAB-CONTAINING ARMS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | POSTPROGRESSION SURVIVAL-TIME | 1ST-LINE COMBINATION CHEMOTHERAPY | KRAS WILD-TYPE | CAPECITABINE PLUS OXALIPLATIN | METASTATIC COLORECTAL-CANCER | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colonic Neoplasms - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Bevacizumab | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Deoxycytidine - adverse effects | Leucovorin - therapeutic use | Cetuximab | Liver Neoplasms - secondary | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Fluorouracil - analogs & derivatives | Membrane Proteins - genetics | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 8, pp. 782 - 789
Summary Background MEK is a member of the MAPK signalling cascade that is commonly activated in melanoma. Direct inhibition of MEK blocks cell proliferation... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | BRAF | ONCOLOGY | RAF | SOMATIC MUTATIONS | PROGRESSION | Skin Neoplasms - drug therapy | United States | Humans | Middle Aged | Melanoma - enzymology | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Uveal Neoplasms - enzymology | Young Adult | Pyridones - administration & dosage | Skin Neoplasms - enzymology | Time Factors | Antineoplastic Agents - adverse effects | DNA Mutational Analysis | Melanoma - genetics | Skin Neoplasms - mortality | Adult | Female | Skin Neoplasms - pathology | MAP Kinase Kinase 1 - antagonists & inhibitors | Uveal Neoplasms - genetics | Uveal Neoplasms - pathology | Drug Administration Schedule | Administration, Oral | Pyrimidinones - adverse effects | Kaplan-Meier Estimate | MAP Kinase Kinase 1 - metabolism | Treatment Outcome | MAP Kinase Kinase 2 - metabolism | Melanoma - pathology | Uveal Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | MAP Kinase Kinase 2 - antagonists & inhibitors | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Uveal Neoplasms - mortality | Aged | Pyrimidinones - administration & dosage | Mutation | Pyridones - adverse effects | Melanoma - mortality | Prevention | Care and treatment | Melanoma | Cancer | Index Medicus
Journal Article
Composites science and technology, ISSN 0266-3538, 2009, Volume 69, Issue 11-12, pp. 1880 - 1886
Journal Article